Pharma VC Funds

Valor Equity Partners, founded in 1995 and based in Chicago, is a leading private equity firm specializing in operational growth investments. The firm strategically invests across various stages of company development, with a keen focus on technology sectors. Valor Equity Partners is renowned for its hands-on approach, working closely with portfolio companies to enhance growth and scalability. The firm's notable investments include SpaceX, a pioneer in aerospace; Gopuff, an on-demand convenience delivery service; Misfits Market, a direct-to-consumer grocery delivery provider; and Zipline, a company revolutionizing autonomous drone delivery systems. Valor's investment strategy emphasizes providing strategic and operational support, ensuring that portfolio companies can achieve substantial growth. Valor Equity Partners manages multiple funds, with their recent Fund V closing at $1.7 billion, underscoring their strong position in the private equity market. The firm's ability to attract significant capital commitments highlights investor confidence in their strategic approach and track record of success. Key team members include founder and CEO Antonio Gracias, who brings extensive experience and leadership to the firm. Valor's team is known for its deep industry knowledge and commitment to driving operational excellence within their portfolio companies. This combination of strategic investment and operational support positions Valor Equity Partners as a pivotal player in fostering innovation and growth within the technology sector.

Valor Ventures is an Atlanta-based venture capital firm that focuses on leading seed-stage investments, primarily in B2B SaaS startups. Established in 2015 by Lisa Calhoun, Valor Ventures aims to create financial disruption in regions outside of Silicon Valley, particularly the rapidly growing Southeastern U.S. With a strong commitment to diversity, Valor’s portfolio is 70% led by underrepresented founders, including women and people of color. Valor Ventures’ investment strategy targets post-product, post-revenue companies experiencing double-digit revenue growth. The firm takes a hands-on approach, providing not only capital but also strategic connections to corporate partners, customer introductions, and operational support through its Innovation Council. Valor's portfolio includes startups such as LeaseQuery, a leader in financial software, Physician360, and CareWork, which unifies operations for senior living facilities. The firm is also known for its Startup Runway Foundation, a nonprofit that connects underrepresented founders to early capital, further reinforcing its mission of making inclusion the norm in venture capital. With a growing portfolio and a focus on fast-growing markets, Valor Ventures continues to position itself as a leading force in the U.S. Southeast startup ecosystem. The team at Valor includes seasoned investors like Lisa Calhoun, Gary Peat, and Lynne Laube, whose combined experience provides invaluable mentorship and strategic insight to portfolio companies.

Value Creation Capital (VCC) is a Netherlands-based venture capital firm that has been actively investing in deep tech companies since 2005. The firm specializes in early-stage investments, primarily focusing on sectors such as AI, cybersecurity, high-tech, and life sciences. Over the years, VCC has successfully built a portfolio of more than 40 tech companies, guiding them through various growth phases​. VCC takes a hands-on approach, offering more than just capital by providing strategic support and access to its extensive network of technology experts. They emphasize the importance of strong, diverse management teams and focus on deep tech companies that create a significant impact on society and business. Their team, led by managing partners such as Aldebert Wiersinga and Jos Bourgonje, is known for being highly involved in the development of the startups they back. The firm also offers a phased growth strategy, recognizing that each stage of a tech company's journey requires different skills and resources.

Vamos Ventures is a Los Angeles-based venture capital firm dedicated to investing in diverse founders, particularly from the Latinx community. Founded by Marcos Gonzalez in 2018, Vamos Ventures focuses on early-stage, tech-driven companies with the potential for high financial returns and significant social impact. The firm's primary investment sectors include Health & Wellness, Future of Work, FinTech, and Sustainability​. Notable investments in their portfolio include Form Energy, a company revolutionizing energy storage; Suma Wealth, a fintech platform focused on financial inclusion for the Latinx community; and SweetBio, a health and wellness startup innovating in wound care​. Vamos Ventures' mission is to create alpha and impact by funding disruptive solutions led by Latinx and diverse founders. The firm emphasizes the importance of community empowerment, social mobility, and representation in the tech ecosystem. They are supported by notable partners such as Apple, Bank of America, and the Ford Foundation​.

Van Herk Ventures is the life-sciences investment arm of Van Herk Groep, the Rotterdam-based family investment group built by Dutch entrepreneur Adriaan van Herk and whose roots trace back to 1951. Operating with patient, evergreen family capital, Van Herk Ventures invests in the life-sciences sector through direct stakes in both private and publicly listed companies as well as commitments to specialist venture capital funds. For private companies it concentrates on the Benelux region and typically participates in businesses with an enterprise value of between roughly EUR 10 million and EUR 150 million at the time of first investment, while its public-market positions extend across the broader European and global biotech landscape, generally as a co-investor. The wider Van Herk Groep deploys across real estate, energy, financial services and construction, but the Ventures vehicle is focused squarely on life sciences, biotechnology and healthtech. Across roughly 28 portfolio companies it has produced eight IPOs and seven acquisitions, with a track record that includes some of Europe's most prominent biotech names, argenx, Merus, Galapagos, Zealand Pharma, BioInvent, DCprime and DermTech, alongside landmark exits such as Ablynx, acquired by Sanofi, and Crucell, acquired by Johnson & Johnson. The group runs a lean team of around ten people including two partners. Backed by patient, multigenerational family capital, Van Herk Ventures takes long-term positions across private and public European life-sciences companies and has built one of the region's most successful biotech investment track records.

Vanedge Capital is an early-stage venture capital firm with offices in Vancouver and Silicon Valley. Founded by experienced technology entrepreneurs, the firm focuses on investing in companies that leverage deep technology and innovative solutions in areas such as hard tech, artificial intelligence, and analytics. Vanedge Capital aims to help visionary technologists build and scale their businesses through capital investment, operational expertise, and a robust network of industry connections. The firm has $390 million under management and has developed a repeatable investment process refined over a decade to deliver superior returns. Their portfolio includes a diverse range of companies such as Canalyst, Cogniac, and Echodyne, each known for their groundbreaking technologies and market impact. Key team members include Moe Kermani, who has extensive experience in cloud computing and machine intelligence, and Amy Rae, who focuses on SaaS businesses and applied analytics. The team provides hands-on support to their portfolio companies, helping them mitigate execution risks and attract follow-on capital from top-tier co-investors.

Vast Ventures is a venture capital firm that focuses on investing in disruptive companies with a global impact. Founded in 2004 by Doug Chertok, the firm is headquartered in New York, New York. Vast Ventures has a diverse portfolio, investing in sectors such as healthcare, finance, AI, cloud software, and sustainability. They have a strong track record with notable investments in companies like Sweetgreen, Conductor, and Clover Health​. The firm's investment strategy centers on fostering innovation and supporting entrepreneurs who aim to create significant positive change. They emphasize long-term partnerships, providing not just capital but also strategic guidance and support to help their portfolio companies grow and succeed​. Vast Ventures is managed by a team of experienced professionals, including Doug Chertok, Aniq Rahman, and Talia Zapolanski. The team leverages their extensive backgrounds in finance, entrepreneurship, and venture capital to help startups navigate the challenges of early-stage growth​. For startups seeking investment, Vast Ventures is particularly interested in companies that aim to improve health and happiness, promote resource sustainability, increase human potential and productivity, and foster knowledge and empathy. They prefer to lead investment rounds and take active roles in the development of their portfolio companies​.

Velvet Sea Ventures is a multi-stage venture capital firm based in New York, founded in 2019 by Kass Lazerow, Matthew Giampetroni, Michael Lazerow, and John Giampetroni. The firm focuses on helping entrepreneurs turn their visions into reality by providing capital and hands-on strategic support. With over 80 years of combined experience and more than $2.2 billion invested, Velvet Sea offers seed-to-growth stage investments across various sectors. The firm is known for backing high-growth companies in industries like human capital services, fintech, and semiconductors. Their diverse portfolio includes companies such as Scopely, Liquid Death, SuperRare, and eToro, emphasizing Velvet Sea's versatility in supporting businesses from gaming to consumer products. Velvet Sea Ventures takes pride in being more than just a capital provider; they partner closely with their portfolio companies to drive innovation and long-term success. Their team has led numerous high-profile investments, including in Autograph and LeoLabs, and they continue to expand their reach across various sectors globally.

Venrock, a venture capital firm born from the Rockefeller family’s pioneering investments, focuses on early-stage companies in healthcare and technology. Its portfolio features high-profile companies like Apple, Intel, and more recently, businesses such as Illumina, and Cloudflare. Venrock operates primarily in the U.S., with offices in Palo Alto, New York, and Cambridge, emphasizing innovation-driven startups. Venrock’s investment strategy targets disruptive ideas in digital health, biotech, enterprise software, and cybersecurity. They prioritize early-stage investments, often leading seed and Series A rounds with checks typically ranging from $5M to $10M. The firm’s disciplined approach includes follow-on investments, ensuring sustained growth. Venrock tends to stay hands-on, offering strategic guidance rather than merely financial support, particularly in sectors with complex technical or regulatory landscapes. With recent funds like Venrock 10, a $650M pool, the firm is increasingly active, especially in biotech and digital therapeutics. Founders should note that Venrock values data-driven pitches and prefers founders with strong domain expertise. Partner Bryan Roberts, a key figure, exemplifies Venrock’s deep involvement in healthcare innovation, while other partners like Brian Ascher are notable for their tech focus. For startups, the ideal approach to Venrock involves showcasing clear scalability and a transformative market vision. Venrock’s long-standing reputation for backing groundbreaking companies is cemented by its proactive role in nurturing bold ideas that shape the future.

Venture Investors Health Fund, also known as Venture Investors and more recently rebranded Clarevia, is one of the Midwest's longest-established healthcare-dedicated venture capital firms, headquartered in Madison, Wisconsin with an office in Ann Arbor, Michigan. Tracing its roots to the early 1980s, when it began as Madison Capital Corporation with just $1M under management, the firm has built a roughly four-decade legacy and today manages around $350M in assets. It invests in early-stage healthcare and life-sciences companies developing patient-facing innovations across biopharmaceuticals and therapeutics, medical devices, diagnostics and tools, and digital health, with historical strength in oncology, infectious disease and ophthalmology and an expanding focus on behavioral and women's health, willing to lead. The firm prefers companies with a Midwest presence but national reach, leveraging its proximity to world-class research universities. In its most recent, seventh, fund it closed $80M, with first-check sizes ranging from $500,000 to $4M and similar or larger amounts reserved for follow-on rounds. New portfolio companies funded include Elephas Biosciences, Rivermark Medical, Sanacor, Ten Bay Bio and EarliTec Diagnostics. Over its history the firm has made well over 100 investments and recorded roughly 50 exits. Its leadership includes Executive Managing Director Jim Adox, longtime Managing Director John Neis, with the firm since 1985, and Principal Jenni Le. By concentrating exclusively on healthcare and life sciences and leveraging its university ties, Venture Investors Health Fund backs early-stage, patient-facing innovation across the Midwest and beyond.

Venture Kick, a leading philanthropic initiative in Switzerland, has been instrumental in supporting early-stage startups since its inception in 2007. The program provides up to CHF 150,000 in pre-seed funding through a structured, three-stage process, aimed at helping science-based startups transition from innovative concepts to market-ready businesses. With a portfolio of over 1,000 supported startups, Venture Kick has contributed significantly to the Swiss startup ecosystem. Their efforts have led to the creation of more than 13,300 jobs and attracted over CHF 8 billion in investments. Notable successes from their alumni include Climeworks, a leader in direct air capture technology, which recently raised CHF 600 million to scale its operations, and YASAI, a vertical farming company that has secured investment from the Bell Food Group to boost its growth​​. The foundation’s focus spans various high-tech sectors, including ICT, life sciences, cleantech, and advanced manufacturing. In 2023 alone, Venture Kick reviewed 781 applications and supported 118 projects, demonstrating its robust selection process and broad industry impact. The initiative aims to scale its model further, with ambitious goals of supporting 3,000 high-tech companies and creating 100,000 jobs by 2033​.

Versant Ventures, founded in 1999, is a leading venture capital firm with a strong focus on the healthcare and biotechnology sectors. Headquartered in San Francisco, the firm also has offices in Basel, New York, San Diego, Toronto, and Vancouver. Versant Ventures manages approximately $4.2 billion in assets and is known for its unique investment model, which includes both funding external companies and developing companies in-house through its discovery engines​. Versant Ventures has made significant investments in groundbreaking biotech companies. Some of their notable investments include CRISPR Therapeutics, a pioneer in gene editing; BlueRock Therapeutics, focused on cell therapy; and precision oncology firms like Black Diamond Therapeutics and Repare Therapeutics. These companies have achieved substantial success, with several going public and making significant advancements in their respective fields​​. The firm's strategy involves creating and nurturing startups from the ground up, providing not only financial support but also access to state-of-the-art laboratories and multidisciplinary teams of scientists. This approach has enabled Versant Ventures to foster innovation and drive the development of novel therapeutics and biotechnology solutions​. For entrepreneurs and startups in the biotech and healthcare sectors, Versant Ventures offers a robust support system and a track record of successful exits and IPOs, making it a key player in advancing medical and scientific breakthroughs.

Vertex Ventures is a global network of venture capital funds with a focus on early-stage investments across various innovation hubs, including China, Israel, Southeast Asia, India, the US, and Japan. Vertex Ventures Japan (VVJ), the newest addition, recently launched its inaugural JPY 10 billion ($64 million) fund, Vertex Ventures Japan Fund I (VVJFI). This fund is dedicated to investing in early-stage Japanese startups with high growth potential, particularly in sectors such as deep tech, digital transformation (DX), artificial intelligence (AI), and the creator economy​. VVJ leverages the extensive global network of Vertex Holdings, which manages over $6 billion in assets and provides strategic support and operational assistance to its portfolio companies. This network allows VVJ to offer Japanese startups access to global markets and resources, fostering innovation and technological advancement​. The fund is led by Managing Partner Takashi Tomita and General Partner Tomohiro Miyasaka, who are responsible for identifying new investment opportunities and driving strategic growth. Vertex Ventures Japan also collaborates with the University of Tokyo and the Japanese government to enhance the startup ecosystem through cross-border partnerships between industry, academia, and government.

VestedWorld is a Chicago-based venture capital firm focused on catalyzing growth in emerging markets, particularly in Sub-Saharan Africa. Founded with a mission to drive sustainable economic development, VestedWorld invests in early-stage companies across sectors such as agribusiness, consumer products, and technology-enabled services. The firm's strategy emphasizes identifying high-growth potential businesses that can create significant economic and social impact in regions often overlooked by traditional investors. VestedWorld operates with a strong belief that the most effective way to alleviate poverty is through economic development. By channeling capital into promising startups in countries like Kenya, Nigeria, and Ghana, the firm aims to foster entrepreneurship, create meaningful jobs, and support the broader economic ecosystem. VestedWorld's approach is not just about providing financial returns to its investors, but also about contributing to the overall prosperity and stability of the regions it invests in. The firm’s leadership, including Managing Director Euler Bropleh, brings extensive experience in both venture capital and emerging markets. They maintain a hands-on approach, working closely with portfolio companies to help them scale and succeed in challenging environments. VestedWorld's impact-driven investment model allows investors to "do well by doing good," aligning financial success with positive social outcomes. With a clear focus on sectors critical to economic development, such as agriculture and technology, VestedWorld is committed to making a transformative impact in some of the world's fastest-growing but undercapitalized markets.

Vickers Venture Partners is a Singapore-headquartered global deep-tech venture capital firm founded in 2005 by Chairman and Founder Dr. Finian Tan together with co-founders Dr. Khalil Binebine, Dr. Jeffrey Chi (Vice Chairman), Dr. Damian Tan, Linda Li and Raymond Kong. From its Singapore base, Vickers operates a true global network with offices in Shanghai, Hong Kong, New York, Miami, Silicon Valley and London. The firm manages approximately $3 billion across six funds and structured co-investment vehicles, including a more than $250 million Fund VI announced in December 2021 with a sharpened deep-tech focus, and it is willing to lead. Its investment mandate centers on disruptive technologies addressing the world's biggest challenges, life sciences and therapeutics, biotech, renewable and clean energy, nanotechnology and advanced materials, applied AI, fintech, and selectively media, telecommunications and consumer, across all major geographies. Across approximately 60 portfolio companies as of December 2024, Vickers has delivered three IPOs and six acquisitions, with named winners including direct-to-consumer apparel pioneer Bonobos, acquired by Walmart, Canadian geothermal energy company Eavor, whose $15M Series A Vickers led in September 2019 as the firm's first Canadian deal, and Aardvark Therapeutics, where Vickers led Series A and B and remained in the $85M Series C of May 2024 before Aardvark's February 2025 NASDAQ IPO at a $342M market cap. Other historic names include Baidu, Focus Media and Scilex Holdings, contributing to a cumulative portfolio market value the firm cites at over $100 billion. Vickers backs global deep-tech founders solving large challenges.

VilCap Investments, founded in 2014 and headquartered in San Francisco, focuses on early-stage impact investing, backing companies that address pressing social and environmental challenges. Their portfolio spans various sectors, including health, education, energy, agriculture, and financial services. Notable investments include Bodhi Health Education, Certintell, Constant Therapy, and iKure in the health sector, and MPOWER Financing, Nepris, and Pear Deck in education. VilCap's investment strategy is deeply rooted in impact, aiming to create long-term prosperity and equity. They typically invest in seed and early-stage companies, with a preference for those that align with their mission of fostering social and environmental change. VilCap Investments often collaborates with Village Capital’s accelerator programs to find and fund innovative entrepreneurs. The firm’s geographic focus includes the United States, India, Africa, and Latin America, reflecting their commitment to global impact. Their investments range from $150,000 to $500,000 in follow-on funding, emphasizing support for high-performing companies. Key team members include Michael Davis, Managing Director, and Victoria Fram, co-founder and advisor. VilCap prefers to be approached through their network, leveraging connections to identify potential investments that align with their values and impact goals​. For startups aiming to engage with VilCap, highlighting a strong alignment with social and environmental impact, alongside a solid business model, will be crucial. Their unique approach blends financial support with strategic guidance to ensure long-term success and sustainability.

Village Global is an early-stage venture capital firm that leverages a robust network of luminary investors to back innovative entrepreneurs from the very start. Based in San Francisco, the firm has garnered support from tech giants like Jeff Bezos, Bill Gates, Mark Zuckerberg, and Reid Hoffman, who also serves as the firm's Chairman​. Village Global focuses on a wide array of industries, including fintech, health, consumer, and enterprise technology. Their portfolio boasts successful investments in companies such as Kapwing, Pogo, and Stitch, highlighting their commitment to backing transformative and high-potential startups​. The firm's investment strategy involves leading pre-seed and seed funding rounds, typically writing checks between $250,000 and $1.5 million. Village Global is noted for its network-centric approach, offering unparalleled access to mentors, follow-on funding, and strategic advice from some of the world's most successful entrepreneurs​. With over $500 million in assets under management, Village Global's team includes influential figures like Anne Dwane and Ben Casnocha, who actively support their portfolio companies through hands-on guidance and connections. For startups looking to partner with Village Global, demonstrating a bold vision and the potential for significant impact is crucial. The firm's unique network-driven model provides startups with the resources and support needed to accelerate their growth from day one.

Vine Ventures, founded in 2019 by Ryan Zurrer, is a venture capital firm headquartered in Zurich, Switzerland, with a strong focus on early-stage investments in the life sciences and technology sectors. The firm has a particular interest in innovative solutions for mental health and wellness, emphasizing the development of psychedelic therapies and healthcare technology systems. Notable investments from Vine Ventures include companies like Alto Neuroscience, which recently went public, and Kocomo, a proptech startup based in Mexico City. Vine Ventures has also backed Remepy, Lykos Therapeutics, and Necto, demonstrating their commitment to advancing healthcare and financial software solutions. Geographically, Vine Ventures invests in the U.S., Latin America, and Israel, reflecting their global reach and diversified portfolio. Their strategic approach involves leading funding rounds and providing substantial support to help startups scale and achieve significant milestones​. The Vine Ventures team boasts experienced professionals like Daniel Tarockoff and Ozan Polat, based in San Francisco and Zurich respectively. Ryan Zurrer, the founder, has a robust background in venture investing and entrepreneurship, particularly in the renewable energy and blockchain sectors. This diverse expertise allows the firm to offer valuable insights and hands-on support to their portfolio companies​. For startups aiming to collaborate with Vine Ventures, it's essential to present innovative, scalable solutions that align with their focus areas. Direct, concise pitches that demonstrate clear market potential and strategic fit are highly valued by the firm. By fostering a collaborative environment and leveraging their extensive network, Vine Ventures continues to drive impactful advancements in the health and wellness sectors.

Virtue VC is an early-stage venture capital firm based in Austin, Texas, that focuses on transforming healthcare through pre-seed and seed-stage investments. Launched in 2021, the firm typically invests between $250,000 and $1 million in healthcare startups, often committing within 7-10 days. Virtue is deeply involved with its portfolio companies, offering patient capital and hands-on support, helping founders with everything from go-to-market strategies to scaling their ventures. Virtue’s portfolio includes a range of innovative companies like Evvy, which focuses on precision vaginal microbiome care, and Amae Health, a value-based care provider for serious mental illnesses. Other standout companies include Mural Health, working on clinical trials infrastructure, and Ryght Ai, specializing in biopharma insights and analytics. Led by Sean Doolan, a veteran in healthcare investment, and Emre Karatas, who brings a focus on digital health and commercialization strategies, Virtue VC targets founders who aim to radically reshape healthcare, rather than just improve existing systems​. They primarily focus on U.S. companies but are open to global opportunities.

Visible Ventures is a venture capital firm that invests in early-stage companies, emphasizing human-centric solutions that drive significant cultural and economic outcomes. Their investment strategy focuses on supporting innovative startups across various sectors, including health, education, fintech, and consumer products. They are particularly committed to championing underrepresented founders, with a strong emphasis on diversity, equity, and inclusion. The firm's portfolio includes notable companies such as Illumix, an augmented reality platform; Ello, a social network for creative communities; Recurate, a recommerce platform for brands; and WaitWhat, a media invention company. Visible Ventures provides not only capital but also strategic guidance, operational support, and a robust network to help their portfolio companies scale and succeed. The team at Visible Ventures consists of experienced investors, operators, and advisors dedicated to supporting early-stage companies and helping them achieve their goals.

Vision Ventures is an early-stage venture capital firm with a focus on supporting bold entrepreneurs across various sectors, particularly in Central and Eastern Europe (CEE). The fund's portfolio spans industries such as AI, SaaS, HR tech, and robotics, featuring notable investments like Sloneek, Airvolute, and BiteBerry. These companies exemplify Vision’s focus on innovation, automation, and simplifying business operations globally. Vision Ventures primarily invests in pre-seed and seed rounds, with an average check size of up to EUR 1.6 million. The firm seeks startups with the potential to scale globally, providing not only financial backing but also strategic advice on growth and market positioning. Vision Ventures takes a hands-on approach, often helping with product development and strategic decisions. Geographically, Vision Ventures is rooted in Slovakia, but their investments and partnerships are spread across Europe, with an increasing interest in global opportunities. Founders should approach Vision Ventures with a clear market strategy and scalability plan, as they highly value data-driven growth models and visionary leadership. The team, led by serial entrepreneur Tomáš Bél, is known for its strong business acumen and deep experience in various industries, making them a reliable partner for navigating the complexities of early-stage growth. In short, Vision Ventures offers much more than capital—they are deeply involved in guiding companies to success, offering expertise across finance, technology, and market development.

Vodia Ventures, the investment arm of Vodia Capital, is a Massachusetts-based venture capital firm that focuses on early-stage investments in companies developing technology-enabled solutions for social and environmental challenges. Founded in 2013, Vodia Ventures targets sectors such as clean energy, healthcare, food security, and sustainable infrastructure. The firm is particularly interested in scalable, impactful technologies that address pressing global issues like climate change and resource scarcity. Vodia Ventures operates by creating specialized investment vehicles such as blind pool and SPV (Special Purpose Vehicle) funds. Their goal is to provide early-stage capital to innovative startups, helping them grow while making a positive impact on society. Some of the industries Vodia Ventures invests in include technology, clean energy, healthcare, and smart infrastructure. Under the leadership of founder David B. Matias, Vodia Ventures continues to play a significant role in fostering innovation by supporting companies that align with its mission of social impact​.

squared Ventures, a Munich-based venture capital firm, focuses on early-stage deep tech investments across Europe. Established in 2016, Vsquared Ventures aims to back scientific and engineering-based innovations that address global challenges. Their areas of focus include AI, next-generation software, energy transition, new computing and sensing, new space, robotics, and tech-bio sectors. The firm recently closed its second fund, Vsquared II, at €214 million, making it the largest early-stage deep tech fund in Europe. This fund will support approximately 25 companies with investments ranging from €500,000 to €5 million, with a significant portion reserved for follow-on investments. Notable investments by Vsquared include Isar Aerospace, a rocket manufacturer; IQM Quantum, a quantum computing hardware provider; and Neura Robotics, a developer of cognitive robotic assistants. The firm is committed to leveraging Europe's strong talent pool and research facilities to build category-leading companies. The team at Vsquared Ventures includes experienced investors and deep tech experts, such as Thomas Oehl, Dr. Herbert Mangesius, and Dr. Lise Rechsteiner, who joined as a General Partner for the latest fund​. They focus on fostering a resilient deep tech ecosystem in Europe, aiming to make significant contributions to technological and economic sovereignty.

VU Venture Partners is a global multi-stage venture capital firm founded in 2018, with headquarters in San Francisco and Hong Kong. The firm is focused on seven key verticals: Consumer, Enterprise, Fintech, Frontier, Healthcare, PropTech, and Web3. With a robust global presence, VU operates in major markets across North America, Europe, Asia-Pacific, and Africa. The firm distinguishes itself through its large, diversified investment team of over 70 professionals, allowing them to source around 20,000 deals annually, a scale far greater than typical venture firms. VU Venture Partners invests in early-stage companies from pre-seed to Series A, making initial investments between $200K and $1M, with the ability to follow up with investments of up to $10M. The firm supports portfolio companies through long-term partnerships, helping them with customer acquisition, strategic introductions, and fundraising, while also reserving capital for follow-on investments. VU has a strong track record of identifying future unicorns, having previously invested in companies such as Uber, Facebook, Venmo, and Beyond Meat. The firm also runs the Venture University accelerator program, which provides individuals with the opportunity to gain real-world investment experience, participate in deal flow, and build their own investment track records while contributing to VU’s success.

Wa’ed Ventures is a $500 million venture capital fund established by Saudi Aramco to promote innovation and economic diversification in Saudi Arabia. The fund focuses on investing in tech-based startups, particularly those involved in sustainability, digitalization, and social impact. Its portfolio includes companies such as Red Sea Farms, which develops sustainable agricultural technology for harsh environments, and Mighty Buildings, a leader in modular construction and 3D printing aimed at reducing housing shortages and environmental impact. Wa’ed Ventures primarily invests in early-stage and growth-stage startups, offering strategic guidance and funding. The average investment ranges between $2 million and $5 million, though the firm is also capable of supporting larger, later-stage investments. Its strategy aligns with Saudi Arabia’s Vision 2030, aiming to foster innovation that contributes to economic diversification, particularly in industries like fintech, logistics, AI, and health tech. Startups interested in partnering with Wa’ed Ventures should demonstrate clear scalability, robust technology, and a strong focus on sustainability. The firm prefers to lead funding rounds and plays a hands-on role in helping its portfolio companies navigate regulatory landscapes and market challenges. The team, led by experienced professionals from sectors like finance and technology, offers significant strategic support to help startups grow and succeed. Wa’ed Ventures is a crucial player in Saudi Arabia’s venture ecosystem, supporting the country's transformation into a tech-driven economy while aligning with global sustainability goals.

Wamda Capital is a leading venture capital firm focused on fostering entrepreneurship in the Middle East, North Africa, and Turkey (MENAT) region. Established in 2014 by Fadi Ghandour, the founder of Aramex, Wamda has invested in over 100 startups, including notable names like Careem, Souq, and Mumzworld. These companies have been critical in shaping the tech ecosystem in the region, with Careem being one of its standout exits following its acquisition by Uber. Wamda Capital’s investment strategy is sector-agnostic, with a particular focus on technology and tech-enabled businesses. The firm typically invests in Seed to Series A rounds, but it also has a flexible approach through its evergreen investment structure, allowing for both early-stage and opportunistic investments. Its portfolio spans industries such as fintech, e-commerce, and digital health, with recent investments in companies like Tabby (fintech) and Insider (AI-based marketing). Wamda is headquartered in Dubai and is well-known for its hands-on approach, working closely with founders to provide strategic guidance, network connections, and access to growth capital. They emphasize scalability and innovation, making them a strong partner for startups aiming to expand across the MENA region. Led by experienced professionals like Fadi Ghandour and Fares Ghandour, Wamda Capital provides not only capital but also deep regional expertise, making it a pivotal player in the MENAT startup landscape.

Wave Capital, founded in 2017 and based in San Francisco, is a venture capital firm that specializes in early-stage investments, particularly in companies that are building marketplaces. The firm was co-founded by Riley Newman, Sara Adler, and David Rosenthal, who bring deep expertise from their experiences at companies like Airbnb and Madrona Venture Group. Wave Capital’s investment strategy is heavily focused on backing startups at their earliest stages—often at the pre-seed and seed levels—where they help founders with everything from building their teams to finding product-market fit. This hands-on approach has positioned them as a key partner for marketplace startups, leveraging their strong networks within Silicon Valley to propel companies toward their Series A rounds and beyond. The firm’s portfolio is diverse, with investments in sectors ranging from blockchain and enterprise software to cleantech and e-commerce. Notable investments include companies like Locale, a food and grocery delivery platform, and Camus Energy, which focuses on renewable energy management systems. In total, Wave Capital has made 27 investments, with several successful exits, including Steady Health and Darwin Homes. Wave Capital’s team is known for its deep operational expertise and its ability to work closely with startups, offering more than just capital by being actively involved in guiding the companies they invest in​.

Wavemaker 360 is a leading venture capital firm focused entirely on healthcare, investing primarily in seed-stage startups. Based in Pasadena, CA, and with an additional office in New York, Wavemaker 360 backs disruptors across health-tech, medical devices, telehealth, digital health, and AI-driven healthcare solutions. Notable investments include companies like UptimeHealth, Savonix, and xCures, with a portfolio spanning over 57 companies across two funds. Wavemaker 360's investment strategy emphasizes collaboration with its extensive network of healthcare-focused Limited Partners (LPs), including industry executives, providers, and organizations. This network gives portfolio companies direct access to expertise and strategic partnerships that help accelerate their growth. Their checks typically range from $250K to $500K, with reserves for follow-on funding. The fund is led by a seasoned team, including Founder John Nackel and General Partners Jay Goss and Eric Marton, who together have over 200 years of combined experience in healthcare and venture capital. Wavemaker 360 actively seeks entrepreneurs addressing major healthcare challenges, aiming to improve patient outcomes, reduce costs, and create new revenue streams for providers. Their approach blends capital investment with strategic support, helping startups navigate complex regulatory environments and scale rapidly​.

Wavemaker Partners is a leading early-stage venture capital firm with dual headquarters in Los Angeles and Singapore. The firm focuses primarily on enterprise, deep tech, and sustainability startups, especially in Southeast Asia and Southern California. Since its founding in 2003, Wavemaker has raised over $600 million and invested in more than 400 companies globally. Key investments include Moka (acquired by Gojek), Wavecell (acquired by 8x8), and Red Dot Payment (acquired by PayU). In Southeast Asia, the firm has been involved with startups like GudangAda, a B2B marketplace, and Transcelestial, which focuses on laser communications. Wavemaker is known for its emphasis on fintech, enterprise software, and deep tech, backing startups that address critical market needs with scalable solutions. Typically leading early rounds, Wavemaker provides financial backing and strategic support, with a strong interest in sectors like AI, quantum computing, and sustainability. Its cross-border presence and active investment strategy make it a major player in the global venture capital landscape.

Wellington Management is a global investment management firm that has expanded its private investing capabilities with a dedicated platform focusing on various sectors and stages of the private markets. This includes early-stage venture capital through to late-stage growth investments. With over $8 billion raised for private investments, the firm leverages its extensive network of over 1,000 investment professionals to provide comprehensive support to its portfolio companies. Wellington's venture capital arm, Wellington Access Ventures (WAV), recently closed its first early-stage fund, Wellington Venture Investments I, with $150 million in commitments. This fund focuses on investing in sectors such as artificial intelligence, DevOps, fintech, digital health, and consumer technology. The WAV team is dedicated to supporting diverse founder-led companies, recognizing the value in partnering with historically overlooked entrepreneurs to drive long-term growth and meaningful change. Key members of the WAV team include Jackson Cummings, Frederik Groce, Sasha McKenzie, and Van Jones. They emphasize closing the access and resource gaps in venture capital, aiming to create a more equitable future by investing in dynamic and ambitious founders from diverse backgrounds. Wellington Management's private investing platform combines deep private market expertise with the firm's broader public market knowledge, providing a robust support system for both investors and entrepreneurs.

Westbound Equity Partners, formerly Concrete Rose Capital, is a venture capital firm headquartered in Menlo Park, California, committed to investing in startups led by underrepresented founders or building solutions focused on diverse communities. Launched initially in 2019, Westbound has grown its impact through its latest $100 million fund, which targets early-stage ventures with a mission to foster generational wealth and diversity in tech. Founders Sean Mendy and Ian Beadle, both seasoned investors, drive the firm’s approach, emphasizing cultural inclusivity and providing robust support through an extensive professional network that includes industry leaders like Andre Iguodala and Jeff Weiner. Westbound’s investment strategy emphasizes financial and social capital, with funds directed to companies demonstrating potential for both high impact and inclusivity, like Esusu and PlanetFWD. Each investment is bolstered by Westbound’s Talent Network, connecting founders with diverse talent pools and advising on company culture to enhance equitable team practices and inclusive product development. This social and financial support framework is designed to break cycles of underrepresentation in venture capital while achieving substantial returns. In addition to direct financial support, the firm reinvests 50% of its profits into minority communities through its foundation, reinforcing Westbound’s commitment to broad, enduring impact. This approach is set to challenge traditional investment structures by prioritizing long-term equity and inclusive growth alongside profitability.

Westlake Village BioPartners is a venture capital firm based in Los Angeles, specializing in life sciences and biotechnology. Founded in 2018 by Beth Seidenberg, M.D., a former general partner at Kleiner Perkins, and Sean Harper, M.D., the firm has raised a total of $1.3 billion across three funds. Their most recent fund, launched in July 2023, raised $450 million to incubate and grow early-stage biotech companies. Westlake Village BioPartners focuses on transformative human therapeutic technologies, investing in companies from their early stages through Series B rounds. Their portfolio includes notable companies such as Latigo Biotherapeutics, which is developing non-opioid pain medicines, and Kyverna Therapeutics, which recently closed an upsized initial public offering. The firm is committed to catalyzing the Los Angeles biotech hub by supporting innovative startups and leveraging their extensive network and expertise in both scientific and business realms. Their leadership team includes experienced professionals like Mira Chaurushiya, Ph.D., and David Allison, Ph.D., who bring deep scientific and venture capital experience to the table.

What If Ventures is a venture capital firm founded in 2020 that primarily invests in mental health, addiction, and stigmatized healthcare services. Based in the United States, What If Ventures is stage-agnostic and provides flexible check sizes, focusing on early-stage investments from seed to pre-IPO. Their portfolio includes companies like TRIPP, Osmind, Alto Neuroscience, Grow Therapy, and Ellipsis Health, which are all focused on innovative solutions in the mental health space. Notable exits include Human API and several IPOs, such as ATAI Life Sciences and Field Trip Health. What If Ventures has deployed $85 million in capital across 72 portfolio companies and has over 4,100 syndicate members. The firm supports startups by addressing the gaps and stigmas in mental health care, aiming to create accessible, affordable, and effective solutions for all.

White Star Capital is a global multi-stage venture capital firm that invests in technology startups with the potential to scale internationally. With a presence in key markets like New York, London, Paris, Toronto, and Singapore, White Star has developed a reputation for backing ambitious entrepreneurs building industry-defining companies across a variety of sectors. White Star focuses on investments in Series A and B rounds, supporting startups in industries such as fintech, digital assets, e-commerce, and healthtech. Some notable portfolio companies include Tier Mobility (a leader in micro-mobility solutions), Freshly (a healthy meal delivery service acquired by Nestlé), and Butternut Box (a fast-growing pet food company). In addition, the firm has made significant strides in blockchain and Web3 technologies through its Digital Asset Fund, which targets crypto networks and blockchain-enabled businesses. The firm’s investment strategy centers around partnering closely with founders, providing not just capital but also strategic support to help startups expand across borders. White Star is deeply committed to ESG (Environmental, Social, and Governance) principles, aligning its investments with sustainability goals. They became a signatory of the UN Principles for Responsible Investment, emphasizing their focus on creating long-term, positive impact. Led by co-founders Eric Martineau-Fortin and Jean-Francois Marcoux, the firm has successfully driven numerous exits, including Dollar Shave Club and Adore Me, reflecting their expertise in scaling companies to global success.

Will Ventures, founded by Isaiah Kacyvenski and Brian Reilly, is an early-stage venture capital firm based in Boston, Massachusetts. The firm focuses on investments across the consumer, healthcare, and media sectors, emphasizing companies that intersect with sports, fitness, and wellness. Their portfolio includes notable investments such as Mighty Health, Elo Health, and Candy Digital, showcasing their commitment to supporting innovative health and fitness solutions​. Will Ventures employs a hands-on approach, actively leading investment rounds and providing strategic support to their portfolio companies. They typically invest in seed and Series A stages, with an average round size of $8 million. Their investment strategy is driven by a deep understanding of the sports and health sectors, leveraging their extensive network and expertise to help startups scale and succeed. The firm is particularly interested in startups that offer scalable, technology-driven solutions in the areas of fitness, nutrition, and digital health. Companies looking to partner with Will Ventures should prepare a concise pitch that highlights their innovative approach, market potential, and strategic fit with Will Ventures' focus areas. With a track record of successful investments and a robust support system, Will Ventures continues to drive impactful advancements in the health and wellness industries.

Willow Growth Partners is a Los Angeles-based early-stage venture capital firm that focuses on investing in emerging consumer brands and the technologies that support them. Founded in 2020 by Deborah Benton and Amanda Schutzbank, the firm aims to back companies that are not only innovative but also values-driven, with a strong emphasis on sustainability and transparency. The firm’s investment strategy is centered around supporting brands with strong underlying unit economics and a clear path to profitability. Willow Growth Partners typically leads the first institutional round of investment and provides extensive hands-on support, helping companies scale efficiently while maintaining their core values. Their inaugural $28 million fund, announced in 2021, reflects this approach, with a portfolio that includes companies like Bubble, Dae, and Coterie, among others. Willow Growth Partners is particularly committed to diversity, with nearly 75% of their portfolio companies led by female or minority founders. The firm’s founders bring a wealth of experience from both venture capital and operating roles, which they leverage to guide their portfolio companies through the challenges of early-stage growth.

Wing Venture Capital, founded in 2013 and based in Palo Alto, California, focuses on early-stage investments in technology companies. The firm primarily invests in sectors such as AI, cybersecurity, big data, SaaS, and enterprise software. Wing is known for its deep engagement with founders, providing extensive support beyond capital to help build significant companies. Notable companies in Wing's portfolio include Snowflake, a data cloud company; Cohesity, a data management firm; and Gong, which uses AI to analyze sales calls. Other prominent investments are Pinecone, a vector database company, and Moogsoft, an AIOps platform for IT incident management. Wing's investment strategy emphasizes long-term partnerships with founders, leveraging their expertise and extensive network to support the growth of portfolio companies. They aim to be actively involved, often taking board seats and providing strategic guidance.

Wireframe Ventures is a venture capital firm founded in 2016, with headquarters in Mill Valley, California, and an expanded presence in New York City. The firm focuses on pre-seed and seed-stage investments, particularly in sectors that positively impact climate and health. Their mission is to back founders driven by a commitment to create innovative solutions that benefit people and the planet. Wireframe Ventures manages several funds, including the recently announced $77 million Wireframe Fund II. This fund is dedicated to supporting early-stage companies aiming to improve environmental sustainability and healthcare. The firm typically invests between $500,000 and $2 million in early-stage companies, often leading or participating in high-quality syndicates. The team at Wireframe Ventures includes co-founders Harsh Patel and Paul Straub, along with other key members such as Lily Bernicker. They bring extensive experience and a hands-on approach to support their portfolio companies from the initial investment through to product-market fit and subsequent funding rounds. Notable investments by Wireframe Ventures include Mammoth Biosciences, SPAN.io, MycoWorks, Electriphi, and Enveda Biosciences. These companies exemplify Wireframe's focus on innovative technologies that address critical issues in health and sustainability. The firm has a strong track record, with over 70% of their portfolio companies raising institutional Series A funding within 15 months of Wireframe's initial investment.

Woodstock Fund is a global venture capital firm with a sharp focus on blockchain technology, decentralized finance (DeFi), and Web 3.0 ecosystems. Founded in 2019, the firm has quickly built a strong portfolio across early and growth-stage companies in sectors such as decentralized protocols, NFTs, and tokenization. Notable investments include Router Protocol, a cross-chain liquidity platform, Transak, a crypto on-ramp provider, and Covalent, a blockchain data querying service. The fund is headquartered in the Cayman Islands with offices in India and the UAE, bridging investment opportunities between Asia, the Middle East, and global markets. Woodstock's investment strategy is highly research-driven, with a focus on emerging technologies that push the boundaries of Web 3.0. They target startups in Series A and pre-seed stages, with check sizes ranging from $1M to $5M. The firm is also active in infrastructure and protocol development, helping to shape governance and ecosystem growth for the projects they back. Woodstock’s investment horizon is long-term, often employing a five-year lockup period for their investors. Led by co-founders Pranav Sharma and Himanshu Yadav, Woodstock Fund has gained a reputation for its deep expertise in decentralized technologies and its hands-on approach to supporting portfolio companies. This commitment is reflected in its strategic role in building infrastructure around blockchain and guiding early-stage startups through the complex landscape of decentralized ecosystems.

Worth Capital is a UK-based venture capital firm that specializes in early-stage investments, focusing on startups with innovative, market-disrupting products or services. They typically invest up to £400,000 in businesses that qualify for the Seed Enterprise Investment Scheme (SEIS) or Enterprise Investment Scheme (EIS). Their investment approach centers around identifying brands that have strong potential for growth and customer loyalty, particularly those operating in fragmented or underserved markets. Worth Capital’s portfolio is diverse, covering both B2B and consumer sectors. Notable investments include Fox Robotics, an agricultural technology company, and Kanda, a fintech solution for tradespeople. The firm values market insight and problem-solving over mere technological hype, emphasizing the importance of founders who understand their markets deeply. Geographically, Worth Capital is committed to supporting UK-based startups, with a significant portion of their investments going to businesses outside of London. Their founders, Matthew Cushen and Paul Soanes, bring decades of entrepreneurial and investment experience, providing not only capital but strategic guidance to help their portfolio companies scale successfully. For startups looking to engage, Worth Capital values clear market strategies and innovation, with a preference for businesses aiming to build enduring, loved brands​.

WuXi Healthcare Ventures was founded in 2011 as the corporate venture arm of WuXi PharmaTech, now WuXi AppTec, the China-based contract research and manufacturing giant. The firm was headquartered in Cambridge, Massachusetts with a second office in Shanghai, China, and ran an explicit cross-border 'find in U.S. and build in China' strategy, identifying promising life sciences companies in the US and supporting their development with access to the China market and WuXi's R&D platform, generally as a co-investor. WuXi Healthcare Ventures II, L.P. closed in December 2015 at $290 million, exceeding its $250M target. Founding leadership included Dr. Ge Li, founder of WuXi PharmaTech, and Edward Hu, CFO/CIO of WuXi AppTec, as non-operating partners, and operating partners including Managing Partner Wei Li. The portfolio spanned both US biotechs and emerging Chinese drug developers, including Twist Bioscience, Unity Biotechnology, Ideaya Bioscience, Syros Pharmaceuticals, CStone Pharmaceuticals, Hua Medicine, Antengene Corporation, Refuge Biotechnologies, XW Laboratories, LifeMine Therapeutics, Vivace Therapeutics and Forerunner Medical. The firm exited several landmark companies including Agios Pharmaceuticals in cancer metabolism, Foundation Medicine, later acquired by Roche, and Juno Therapeutics, later acquired by Celgene. On May 18, 2017, WuXi Healthcare Ventures merged with Frontline BioVentures to form 6 Dimensions Capital, an approximately $800M AUM biotech-focused VC chaired by Ge Li with Frontline founder Dr. Leon Chen as CEO. New investment activity is now conducted under the 6 Dimensions Capital brand. With its cross-border model, WuXi Healthcare Ventures bridged US life-sciences innovation and the China market.

Xenia Venture Capital is an Israeli high-tech and life sciences investment company founded in 2003 and publicly traded on the Tel Aviv Stock Exchange. Headquartered in Tel Aviv, Xenia invests in early-stage Israeli companies across high-tech and medical technology, with an increasing focus on life sciences. A core element of its platform is a 50% stake in VLX, a technological incubator operating under the Israel Innovation Authority's incubator program that supports data-driven biotech, pharma and digital-pharma startups. Beyond capital, Xenia provides portfolio companies with mentoring, business and strategic counseling, fundraising assistance, exit planning, and shared back-office infrastructure, finance, accounting, logistics and office support, services well suited to first-time scientific founders coming out of academia or the Israeli Innovation Authority incubator pipeline, and it generally invests as a co-investor. Since inception the firm has invested in more than 40 companies and notched one IPO and at least six acquisitions; flagship outcomes include the June 2020 NASDAQ IPO of PolyPid at roughly a $273M market cap, the acquisition of orthopedic device company OrthoSpace by Stryker, and the 2021 exit of MEC software vendor Saguna. Recent activity remains steady, with its most recent reported investment on April 8, 2025 in Arcuro Medical in surgical devices. The firm's leadership has included CEO Lars Thoren and previously Eli Sorzon, and the team comprises roughly eight people including seven partners. By pairing capital with incubation and back-office support, Xenia Venture Capital backs early-stage Israeli high-tech and life-sciences founders.

XFactor Ventures, founded in 2017 and based in New York, is a venture capital firm that focuses on pre-seed and seed-stage investments in companies with at least one female founder. Their mission is to support ambitious entrepreneurs who possess the "X Factor" and the drive to build billion-dollar companies. The firm is known for backing diverse and innovative startups across various sectors, including health tech, AI, e-commerce, and enterprise software. XFactor Ventures has made significant investments in companies like Chief, a private network for women leaders, and MixLab, a provider of personalized pet medications. They have seen successful exits from companies such as Clara Labs, The Inside, and Park Place Payments. The team at XFactor Ventures includes experienced entrepreneurs and investors like co-founders Anna Palmer and Charles Hazard Jr. The firm prides itself on a hands-on approach, providing invaluable resources and guidance to help founders navigate challenges and scale their businesses effectively. XFactor Ventures is part of the Flybridge Capital Partners community, which offers additional support and resources to its portfolio companies. The firm encourages concise and clear pitches from startups that align with their investment focus​.

Xfund is an early-stage venture capital firm that supports lateral thinkers and entrepreneurs who experiment across disciplines. Established in 2014 through a unique partnership with leading venture capital firms and top research universities, Xfund is co-managed by Patrick Chung and Brandon Farwell. The firm focuses on backing founders with multidisciplinary skills and a strong commitment to innovation and execution. Xfund aims to invest in individuals who are not only technically proficient but also possess a deep understanding of their field's broader implications. Their investment approach is designed to provide significant value through a combination of venture capital expertise, university partnerships, and industry connections. This structure allows Xfund to offer unparalleled support to its portfolio companies. The firm has raised several funds, including the latest, Xfund 3, which closed at $120 million. This fund continues Xfund's mission of fostering university-based innovation and supporting startups across various stages of growth. Xfund's notable investments include companies like Philo, Kensho, and 23andMe, reflecting their commitment to high-impact ventures. Xfund operates out of Cambridge, Massachusetts, and Palo Alto, California, reinforcing its connection to leading academic and innovation hubs. For more information, you can visit their official website at xfund.com.

Y Combinator, a premier startup accelerator, has backed some of the world's most successful companies, including Airbnb, Dropbox, and Stripe. The fund's portfolio is impressive, boasting over 5,000 startups with more than 290 private companies valued over $150 million and over 90 valued at more than $1 billion​. Y Combinator's investment focus spans several industries, primarily B2B software and services (43%), financial technology (19%), consumer (13%), and healthcare (12%)​​. Geographically, YC is centered in Silicon Valley, with 59% of its companies headquartered in the Bay Area, but it also supports startups globally, including in countries like India, the UK, and Nigeria​​. YC's strategy involves investing $150,000 in a large number of startups twice a year, providing them with three months of intensive mentorship, networking, and resources. They prefer to invest in early-stage startups and often continue to support companies through follow-on funding rounds​. The typical check size is $150,000, and YC often leads the initial seed rounds. Recently, they've been very active, continuously adding new companies to their portfolio and expanding their global reach​​. Approaching YC involves applying for their biannual batches, with a focus on showing strong product-market fit and growth potential. The team is led by notable figures such as Michael Seibel, the CEO, who brings a wealth of experience in startup growth and acceleration. YC's network of alumni and mentors is a key asset, providing ongoing support and advice to new startups​.

Yes VC, founded in 2018 by Caterina Fake and Jyri Engeström, is a venture capital firm based in San Francisco that focuses on investing in pre-seed and seed-stage startups. The firm is known for backing category-defining companies across a diverse range of industries, including artificial intelligence, climate tech, consumer brands, and digital infrastructure. Notable investments from Yes VC's portfolio include Adept AI, Boom Supersonic, and Lovevery. Adept AI is working on developing general intelligence by enabling humans and computers to collaborate creatively, while Boom Supersonic is building a non-fossil-powered supersonic passenger plane. Lovevery creates award-winning, Montessori-inspired toys and subscription boxes for babies and toddlers. Yes VC is also actively investing in climate tech, with companies like Running Tide, which focuses on carbon sequestration by growing biomass and sinking it in the deep ocean, and Steady Energy, which is developing zero-emission heating plants powered by advanced nuclear reactors. Additionally, the firm supports innovative digital infrastructure solutions, such as OneSignal, a customer engagement platform, and Reconnect, which improves outcomes for individuals in the criminal justice system. The firm's commitment to diversity is evident, with a significant portion of its investments going into companies founded by women or people of color. This approach aligns with their mission to support transformative technologies and innovative business models that have the potential to make a substantial impact.

The Yield Lab is a venture capital firm dedicated to transforming the agri-food sector by investing in early-stage companies across North America, Europe, Latin America, and Asia Pacific. Their portfolio includes notable startups such as Pluton Biosciences, which specializes in biotech innovations, and GroGuru, which focuses on strategic irrigation management for farmers. With a geographic focus that spans multiple continents, The Yield Lab invests in high-impact companies with technologies in areas like digital agriculture, crop health, and sustainable farming practices. Their investment strategy typically involves funding from $100,000 to $1.5 million for early-stage ventures, providing not just capital but also access to a global network of experts and industry partners to help scale and commercialize these innovations internationally. The Yield Lab has a keen focus on sustainability and aims to support companies that can revolutionize food systems and contribute to environmental conservation. For instance, their investment in RootWave, a company using electricides for sustainable weed control, reflects their commitment to eco-friendly solutions. Key team members include Pat Pinkston and Sherri Brown in North America, and Paul Finnerty and Brian Clevinger in Europe, all of whom bring extensive experience in venture capital and agri-food industries. They maintain a collaborative approach, leveraging their combined expertise to drive growth and innovation within their portfolio companies.

Yonjin Venture LLC is a life sciences-focused venture capital firm established in 2018 and headquartered in Cambridge, Massachusetts. The firm operates as the North America and Europe investment arm of Shanghai-based Yongjin Group, founded in 1995, which positions itself as a diversified capital-markets financial-services institution. Yonjin's sister vehicle is China-based Yonghua Capital, and the two share parent-level resources and deal flow. Yonjin Venture's mandate is early- to mid-stage life sciences, specifically therapeutic drug discovery, diagnostics and medical devices, and it routinely participates as a syndicate co-investor alongside leading US biotech specialists rather than as a lead investor. The team is reported at roughly 10 people including 7 partners. Public portfolio companies include Rapafusyn Pharmaceuticals in drug discovery, its most recent investment in September 2025, CSA Medical, a Series D-II in September 2024, HistoSonics, a focused-ultrasound therapeutic platform, TECLens in ophthalmology devices, Libra Therapeutics in neurodegeneration, a Series A co-led with Boehringer Ingelheim Venture Fund, and OncoResponse in cancer-immunotherapy antibodies, co-invested alongside MD Anderson, ARCH Venture Partners, Canaan Partners, Redmile and GreatPoint. To date the firm has roughly 17 reported investments and one IPO exit, C4 Therapeutics, which went public in October 2020. Fund size and AUM are not publicly disclosed. As the North America and Europe arm of a Chinese financial-services group, Yonjin Ventures co-invests alongside leading US biotech specialists in early- to mid-stage therapeutics, diagnostics and medical devices.

Zeno Ventures, founded in 2016 by Christopher Kile and Duarte Moreira, focuses on early to growth-stage investments in high-potential technology companies. Based in San Francisco, Zeno Ventures primarily invests in consumer and enterprise markets, including transportation, logistics, fintech, and 3D printing sectors. Their notable investments include AvantStay, a hospitality tech startup; Mighty Buildings, a construction tech company; and Mercury, a fintech platform​. Zeno Ventures typically invests around $7 million per round and averages about three transactions per year. While they occasionally lead investment rounds, they often co-invest with other prominent firms like Khosla Ventures and Bold Capital Partners. The firm is known for its collaborative approach, sharing opportunities and working closely with other investors to support portfolio companies throughout their growth. The key team members, Christopher Kile and Duarte Moreira, bring extensive experience in venture capital and entrepreneurship. They focus on building strong relationships with founders and providing strategic support to scale their businesses. Zeno Ventures' geographic focus spans primarily the United States, with a significant presence in tech hubs like San Francisco and Los Angeles. For startups looking to partner with Zeno Ventures, it's essential to demonstrate exceptional management and high growth potential in their pitch. Approaching the firm through warm introductions and showcasing alignment with their investment thesis increases the likelihood of securing an investment.

Zetta Venture Partners is a San Francisco-based venture capital firm founded in 2013 by Mark Gorenberg. The firm focuses exclusively on early-stage investments in AI-driven B2B companies. Zetta's portfolio includes prominent startups such as Clearbit, Lilt, and Opsani, which highlight their commitment to the intelligent software sector. Zetta Venture Partners targets companies in North America and Europe, providing initial investments ranging from seed to Series B stages. The firm's strategy emphasizes hands-on support for founders, particularly in scaling AI models into market-leading products and infrastructures. They position themselves as crucial partners to impactful AI and infrastructure startups, offering expertise in areas like business development, strategic partnerships, and scaling operations. The team includes experienced professionals like Managing Directors Jocelyn Goldfein and Apoorva Pandhi, based in San Francisco, and Partner Dylan Reid in New York. They have a robust network of operators and advisors, ensuring startups receive comprehensive support throughout their growth journey. Zetta's investments are deeply rooted in AI applications and infrastructure, reinforcing their belief in the transformative potential of AI across various industries. This focus has allowed them to build a portfolio that not only aims for financial returns but also contributes significantly to technological advancements. By leveraging their extensive industry connections and deep technical expertise, Zetta Venture Partners helps AI-driven startups navigate the complexities of market entry and growth, making them a formidable player in the venture capital landscape​.